NES and ependymoma: Using nestin as a CSC biomarker, they found that nestin-expressing CSCs in glioblastoma (GBM), medulloblastoma, ependymoma, and oligodendroglioma were significantly closer to tumor blood vessels than tumor cells not expressing nestin.